The new coronavirus appears to repel another vaccine, as according to the Russian Sputnik V vaccine, 91.6% are effective against symptomatic cases of COVID-19 and 100% effective against severe and moderate cases, according to CNN.
- The results were published in The Lancet on Tuesday.
What the numbers say
The data come from Phase 3 trial results, which included 19,866 participants. About 75% of participants (14,964) received two doses of the vaccine and 4,902 received a placebo via CNN.
- There were 16 confirmed cases of symptomatic COVID-19 among those who received the vaccine.
- According to the data, there were 62 cases of COVID-19 among the placebo group.
- The vaccine also analyzed patients older than 60 years and found that the vaccine was 91.8% effective for those older than that age, reports Politico.
Context
In August 2020, Russian President Vladimir Putin said that the country had the first vaccination against coronavirus, about which I wrote for Deseret News. He said he even tested the vaccine on his daughter.
At the time, dr. Scott Gottlieb, the former U.S. Food and Drug Administration commissioner, told CNBC that he would not use the COVID-19 vaccine from Russia because there were no clinical trial data proving it was successful.
- “They cost the equivalent of a phase 1 clinical trial to place it in 100 to maybe as many as 300 patients, so it needs to be evaluated in a large-scale clinical trial.”
Later, in September, a peer-reviewed study in The Lancet found that Russia’s potential coronavirus vaccine had no major side effects, as I wrote on the Deseret News.